• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home Genetics

Rapid genotyping for variant associated with aminoglycoside-induced ototoxicity is feasible in acute neonatal setting

byMolly MunsellandAlex Gipsman, MD
April 6, 2022
in Genetics, Infectious Disease, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a prospective implementation trial, more than 400 infants were tested for the MT-RNR1 m.1555A>G variant using a point-of-care buccal swab test in neonatal intensive care units (NICUs).

2. In a real-world setting, 80.6% of infants treated with aminoglycosides were successfully tested for the m.1555A>G variant with a sensitivity of 100% and specificity of 99.2%.

Evidence Rating Level: 2 (Good)

Study Rundown: Specific genetic variants, including MT-RNR1 m.1555A>G, are associated with increased risk of aminoglycoside-induced ototoxicity (AIO). This study aimed to determine the diagnostic accuracy and feasibility of a rapid point-of-care genotyping assay for the m.1555A>G variant in the neonatal intensive care unit (NICU) setting, where gentamicin is often used to treat neonatal sepsis. A case-control study was conducted for preclinical assay validation. Based on testing of about 160 neonates in comparison with Sanger sequencing, the assay had a sensitivity and specificity of 100% without cross-reactivity. A prospective trial was then conducted examining real-world implementation of this buccal swab test in NICUs. 424 neonates were tested for the m.1555A>G variant, representing 80.6% of infants who were prescribed aminoglycosides. 17.1% of point-of-care tests failed. After implementation of the rapid test, time to antibiotic therapy was essentially unchanged at 55 minutes. Testing returned 3 true positive and 5 false positive results; all of these infants received a cephalosporin antibiotic rather than gentamicin. This study demonstrates encouraging validation data on a genotyping test that is far more clinically useful in high-stakes clinical settings such as suspected neonatal sepsis than existing, slower assays. The balance between cost and benefit of universal genotypic screening must certainly be considered here, particularly in light of this test’s rates of failure and false positives. Though the m.1555A>G variant is present in only about 0.2% of the population and the penetrance of the ototoxicity risk phenotype is unclear, preventing avoidable neonatal hearing loss must also be considered a high-priority goal.

Click to read the study in JAMA Pediatrics

Click to read an accompanying editorial in JAMA Pediatrics

Relevant Reading: Benefit of preemptive pharmacogenetic information on clinical outcome

RELATED REPORTS

Diagnostic tool may help identify cerebral palsy regardless of encephalopathy features

Post-operative exclusive human milk diet improves growth in neonates with single ventricle physiology

Double embryo transfer may be associated with neonatal risks

In-Depth [prospective cohort]: All patients treated at 2 NICUs in the United Kingdom in 2020 were eligible for inclusion. At both centers, benzylpenicillin and gentamicin are used as empiric therapy for suspected bacterial infection before 28 days, while gentamicin in combination with other antibiotics is used for infants older than 28 days. Patients who were determined to require immediate antibiotic therapy on admission were excluded. Subjects had a median age of 2.5 days, and 70% of included neonates received antibiotic therapy. The real-world sensitivity of the assay was 100% with a 95% confidence interval (CI) of 29.2-100%, while the real-world specificity was 99.2% (98-99.7%). A design update to the point-of-care testing system and a change in the assay preparation process were made during the trial and resulted in reduced rates of test failure.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: aminoglycosidesgenomicsneonatologyNICUrapid testing
Previous Post

Oral gefapixant reduces frequency of refractory or unexplained chronic coughs

Next Post

#VisualAbstract: Tumor response-adapted treatment based on radiotherapy may improve rates of laryngeal preservation

RelatedReports

“No Evidence of Disease Activity” may be useful goal in multiple sclerosis
Chronic Disease

Diagnostic tool may help identify cerebral palsy regardless of encephalopathy features

January 26, 2023
Cardiology

Post-operative exclusive human milk diet improves growth in neonates with single ventricle physiology

December 20, 2022
Assisted conception not associated with increased pediatric cancer risk
Endocrinology

Double embryo transfer may be associated with neonatal risks

December 19, 2022
Combined MRI and NIH stroke scores may predict stroke prognosis
Chronic Disease

Maternal unintentional injury during pregnancy associated with higher risk of cerebral palsy

December 9, 2022
Next Post
#VisualAbstract: Neoadjuvant HD201 shows similar efficacy to referent trastuzumab for ERBB2-positive breast cancer

#VisualAbstract: Tumor response-adapted treatment based on radiotherapy may improve rates of laryngeal preservation

Women electing abortion more likely to be victims of domestic violence

Glyburide non-inferior to insulin for perinatal outcomes in gestational diabetes

RTS,SA/S01 anti-malarial vaccine efficacy wanes significantly over time

Chlorfenapyr insecticidal nets provide strong protection against malaria in sub-Saharan Africa

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Aspirin thromboprophylaxis noninferior to low-molecular-weight heparin in patients with fractures
  • Catheter ablation reduces rates of persistent atrial fibrillation and atrial tachyarrhythmia
  • Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options